Federal Policy
Latest
- Federal Policy
MACPAC Seeks Contractor for T-MSIS Data Analysis Services
The Medicaid and CHIP Payment and Access Commission issued a request for proposals for an indefinite delivery indefinite quantity contract to provide computing and data analysis services using the Transformed Medicaid Statistical Information System and other datasets. The contract will support MACPAC's ongoing research and policy analysis work. Proposals are being solicited through SAM.gov. This procurement reflects MACPAC's continued reliance on T-MSIS data for assessing Medicaid program performance, payment policy, and beneficiary access — research that informs Congressional action and CMS guidance affecting managed care plans.
- Federal Policy
USCIS Tightens Adjustment of Status Rules for Green Card Applicants
On May 21, 2026, USCIS issued a policy memo restricting adjustment of status applications, requiring applicants to demonstrate extraordinary circumstances to obtain lawful permanent residence without consular processing. The memo recharacterizes adjustment of status as discretionary relief rather than a routine pathway. This change affects healthcare organizations that sponsor foreign-born clinical staff and may complicate workforce planning for Medicaid managed care plans that rely on immigrant physicians, nurses, and behavioral health providers in shortage areas. Plans should review existing sponsorship pipelines and anticipate longer credentialing timelines.
- Federal Policy
Child Medicaid and CHIP Enrollment Drops by 2 Million Since January 2025
Medicaid and CHIP enrollment among children declined by 2 million between January 2025 and April 2026, according to state-by-state enrollment data. The drop suggests a rising child uninsured rate during this period. The enrollment decline affects managed care organizations through reduced membership and capitation revenue, particularly in states with high CHIP and Medicaid managed care penetration. Plans should monitor monthly enrollment reports and assess financial impacts from membership losses in pediatric populations.
- Federal Policy
Trump Administration Pharmaceutical Pricing Agreements Face Implementation Questions
The Trump administration's most favored nation (MFN) pricing agreements with pharmaceutical manufacturers remain under scrutiny as implementation details emerge. These agreements aim to tie U.S. drug prices to lower international reference prices. Medicaid managed care organizations may see indirect effects through pharmacy benefit design and supplemental rebate negotiations, though the agreements primarily target Medicare Part B and Part D. The timing and scope of implementation remain uncertain, creating planning challenges for health plans managing pharmacy benefits across multiple programs.
- Federal Policy
CMS Proposes Payment Limits on State Directed Payments and Targeted Fee-for-Service Rates
CMS published a proposed rule on May 22, 2026, that would impose payment limits on additional state directed payments in Medicaid managed care and establish new limits for targeted fee-for-service payments. The rule draws authority from section 71116 of H.R. 1 (the "One Big Beautiful Bill Act") and presidential directives. State directed payments allow states to require managed care organizations to adopt specific provider payment arrangements, and new limits could constrain state flexibility in setting enhanced reimbursement rates for hospitals, nursing facilities, and other providers. The proposal would affect how states design rate strategies and could require MCOs to renegotiate provider contracts if existing SDP arrangements exceed new federal limits.
- Federal Policy
CMS Proposes FY 2027 IPPS Payment Updates, Quality Measures, Joint Replacement Model Expansion
CMS released the FY 2027 Inpatient Prospective Payment System proposed rule updating Medicare hospital payment rates, uncompensated care payments, and graduate medical education residency program definitions. The rule expands the CJR-X joint replacement payment model and solicits comment on new quality measures. While IPPS primarily governs Medicare fee-for-service hospital payments, changes to quality measures and payment methodologies often influence Medicaid managed care quality programs and hospital contract negotiations. The comment period timeline was not specified in the excerpt.
- Federal Policy
OIG Clears Limited Free Orthodontic Services in Advisory Opinion 26-09
On May 1, 2026, OIG issued Advisory Opinion 26-09 addressing a pediatric dental and orthodontic provider's proposal to offer free orthodontic treatment to one patient annually at each of its three practice locations. The opinion provides guidance on how such charitable arrangements may comply with federal anti-kickback statute and beneficiary inducement provisions. For Medicaid managed care dental plans and MCOs with dental benefits, this opinion clarifies acceptable parameters for provider charitable care arrangements that could affect network adequacy and access strategies, particularly for orthodontic services where cost barriers are common.
- Federal Policy
CMS pauses Medicare enrollment for home health and hospice providers
CMS has temporarily halted new provider enrollment for home health and hospice services in Medicare, though specific details on duration and scope are not provided in the brief announcement. The enrollment pause likely reflects heightened scrutiny of fraud vulnerabilities in these sectors, which have been subjects of recent OIG investigations. Medicaid managed care organizations with delegated or integrated home health and hospice networks should monitor whether similar restrictions emerge in their contracts or state programs, particularly for dual-eligible populations where Medicare enrollment status affects network adequacy.
- Federal Policy
CMS Recharters Medicare Lab Test Advisory Panel, Announces July 2026 Meeting
CMS has rechartered the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests and appointed five new members. The panel will meet July 14-15, 2026, to advise HHS and CMS on clinical diagnostic laboratory test issues under Medicare. While focused on Medicare, decisions on laboratory test coverage and payment often influence Medicaid managed care plan policies for diagnostic services, particularly for dual-eligible populations and carve-in lab benefits. State Medicaid programs frequently align lab fee schedules and coverage criteria with Medicare determinations.
- Federal Policy · CA
CMS Defers Federal Medicaid Matching Funds to California, Second Such Action
CMS has announced a deferral of federal Medicaid matching funds to California, marking only the second time in Medicaid's 60-year history such action has been taken. Vice President J.D. Vance announced the deferral at a White House press conference, following a similar announcement on February 25. Federal financial participation deferrals represent CMS's most severe enforcement tool and typically indicate suspected fraud, waste, or abuse requiring state corrective action. The action creates immediate cash flow implications for California's Medicaid program and may signal broader federal enforcement priorities affecting managed care oversight.
- Federal Policy · MN
CMS Threatens $515M Federal Funds Withhold from Minnesota Medicaid Over Fraud Concerns
CMS Administrator Dr. Mehmet Oz, with support from Vice President J.D. Vance, initiated a two-pronged action against Minnesota's Medicaid program on January 6, threatening to withhold $515 million in federal matching funds. The action centers on alleged fraud concerns within the state's Medicaid program. The article suggests this fiscal enforcement action may be reaching resolution. Minnesota managed care plans and state officials face potential significant federal funding disruptions pending CMS review of state compliance with program integrity requirements.
- Federal Policy
NHeLP Outlines State Strategies to Mitigate OBBBA Administrative Burdens on Medicaid Eligibility
The National Health Law Program published guidance for states on mitigating administrative challenges created by the One Big Beautiful Bill Act (OBBBA). The legislation imposes more frequent renewals, work requirements, and additional eligibility checks that will increase strain on state Medicaid agencies and enrollees, particularly individuals with disabilities. NHeLP recommends states prepare operational "landing pads" to prevent coverage disruptions as these changes take effect. The guidance is critical for managed care organizations whose enrollment stability and member outreach will be directly affected by states' administrative capacity during implementation.
- Federal Policy
NHeLP Launches Weekly Medicaid Work Requirements Implementation Tracker
The National Health Law Program has begun publishing a weekly series addressing Medicaid work requirements and implementation issues under the One Big Beautiful Bill Act. The resource aims to help advocates monitor federal and state agency actions as policy changes roll out. The series will provide practical guidance on emerging compliance and operational issues. This matters for MCOs because work requirements typically impose new eligibility verification, enrollment monitoring, and reporting obligations on plans under contract with states implementing these policies.
- Federal Policy
FDA Relaxes Oversight of Blood Pressure Wearables, Raising Clinical Accuracy Concerns
The FDA has relaxed regulatory oversight of wellness wearable devices, allowing blood pressure monitoring technology to enter the market without clinical validation. This policy shift enables consumer devices with unverified accuracy to proliferate, potentially affecting remote patient monitoring programs that Medicaid managed care organizations use for hypertension management and chronic disease monitoring. MCOs relying on wearable data for care management and quality metrics should assess whether their contracted devices meet clinical accuracy standards, particularly for programs serving members with cardiovascular conditions.
- Federal Policy
CMS Finalizes 2027 Exchange Payment Parameters, Expands Hardship Exemptions, Revises QHP Standards
CMS issued final 2027 benefit and payment parameters for federally-facilitated exchanges, modifying risk adjustment methodology, HHS-RADV processes, and user fee rates for QHP issuers. The rule codifies expanded hardship exemption eligibility, establishes new provider access and essential community provider standards for QHP certification, prohibits routine non-pediatric dental services as essential health benefits, and allows catastrophic plans with up to 10-year terms. Changes take effect for plan year 2027. While focused on individual and small group exchange markets, provisions affecting network adequacy standards, civil money penalties, and broker oversight may inform state Medicaid managed care oversight frameworks.
- Federal Policy
CMS Corrects Technical Errors in FY 2027 IPPS Proposed Rule
CMS issued a correction notice for technical and typographical errors in the FY 2027 Hospital Inpatient Prospective Payment System proposed rule published April 14, 2026. The correction addresses errors in the original proposed rule covering Medicare payment rates for acute care hospitals and long-term care hospitals, along with quality program requirements. Stakeholders reviewing the proposed rule for comment should incorporate these corrections when preparing submissions. While this is a Medicare-focused rule, Medicaid managed care organizations with dual-eligible populations or Medicare Advantage Special Needs Plans should monitor for cross-program policy implications affecting hospital contracting and quality metrics.
- Federal Policy
CMS Opens 60-Day Comment Period on Information Collection Request
The Centers for Medicare & Medicaid Services has published a Federal Register notice announcing a proposed information collection activity under the Paperwork Reduction Act of 1995. The agency is soliciting public comments on burden estimates, necessity and utility of the proposed collection, accuracy of burden estimates, and ways to enhance data quality or reduce reporting burden through automation. Comments are due 60 days from publication. This matters for MCOs because information collection requirements often translate to new reporting obligations, quality measure submissions, or encounter data specifications that affect plan operations and compliance costs.
- Federal Policy
CMS Seeks Comment on Medicaid and CHIP Generic Paperwork Clearance Process
The Centers for Medicare & Medicaid Services is requesting public comment on information collection activities under its generic Paperwork Reduction Act clearance process (control number 0938-1148). The umbrella approval, last renewed in April 2021, covers voluntary, low-burden data collection related to Medicaid and CHIP state plan amendments, waivers, demonstrations, and reporting. CMS is inviting stakeholders to comment on burden estimates, necessity of proposed collections, and opportunities to reduce administrative requirements. Comments are particularly relevant for states and managed care organizations that submit routine program updates and compliance documentation to CMS.
- Federal Policy
CMS Opens 60-Day Comment Period on Paperwork Reduction Act Information Collection
CMS announced a Federal Register notice seeking public comment on a proposed information collection under the Paperwork Reduction Act. The agency is soliciting feedback on burden estimates, necessity of the collection, and ways to streamline reporting requirements. Comments are due 60 days from publication. This notice matters to Medicaid managed care organizations because PRA collections often involve reporting requirements for health plans, including quality measures, encounter data, or network adequacy documentation that affect operational compliance costs.
- Federal Policy
CMS Opens 60-Day Comment Period on Proposed Information Collection Requirements
The Centers for Medicare & Medicaid Services is soliciting public comment on a proposed information collection under the Paperwork Reduction Act. The 60-day comment period allows stakeholders to weigh in on burden estimates, necessity of the collection, and potential use of automation to reduce reporting burden. CMS has not specified which programs or reporting requirements are affected in this notice. Managed care organizations should monitor the Federal Register for details on whether MCO reporting, quality measures, or network adequacy documentation are subject to this collection.